Investing Shift: Big Tech Down, Pharma Up, Dollar Risks Ahead
Big tech is stumbling while pharma stocks surge, what does that mean for markets heading into 2026? In this episode, Anthony and Piers unpack why Nvidia, Microsoft, and Amazon are dragging, while Eli Lilly and Merck lead a surprising rotation. They also explore shifting Fed rate cut expectations, conflicting US labor…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Market Maker
See all episodes →
Similar episodes from other shows
More like Market Maker →
Fed Interest Rate cuts, Timing your Exponential Exit & Elon Musks $17 Billion Trade
Big Tech Bets on “Overinvesting”
What an AI slowdown could mean for investors
MM #253: Market Meltdown: Trump Goes Nuclear on Tariffs, Best Stock Deals, Global Recession & China’s Revenge
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.